Common Contracts
8 similar Advance Purchase Agreement contracts
ADVANCE PURCHASE AGREEMENT (“APA”) FOR THE PRODUCTION, PURCHASE AND SUPPLY OF A COVID-19 VACCINE IN THE EUROPEAN UNIONAdvance Purchase Agreement • February 15th, 2023
This Advance Purchase Agreement (this “Agreement”) for the production, purchase and supply of the ChAdOx1 nCov-19 vaccine (“Vaccine”) in the European Union (the “EU”) is entered into as of 27 August 2020 (the “Effective Date”), by the following parties:
ADVANCE PURCHASE AGREEMENT (“APA”) FOR THE PRODUCTION, PURCHASE AND SUPPLY OF A COVID-19 VACCINE IN THE EUROPEAN UNIONAdvance Purchase Agreement • November 29th, 2022
This Advance Purchase Agreement (this “Agreement”) for the production, purchase and supply of the ChAdOx1 nCov-19 vaccine (“Vaccine”) in the European Union (the “EU”) is entered into as of 27 August 2020 (the “Effective Date”), by the following parties:
ADVANCE PURCHASE AGREEMENT (“APA”) FOR THE PRODUCTION, PURCHASE AND SUPPLY OF A COVID-19 VACCINE IN THE EUROPEAN UNIONAdvance Purchase Agreement • February 3rd, 2021
This Advance Purchase Agreement (this “Agreement”) for the production, purchase and supply of the ChAdOx1 nCov-19 vaccine (“Vaccine”) in the European Union (the “EU”) is entered into as of 27 August 2020 (the “Effective Date”), by the following parties:
ADVANCE PURCHASE AGREEMENT (“APA”) FOR THE PRODUCTION, PURCHASE AND SUPPLY OF A COVID-19 VACCINE IN THE EUROPEAN UNIONAdvance Purchase Agreement • January 30th, 2021
This Advance Purchase Agreement (this “Agreement”) for the production, purchase and supply of the ChAdOx1 nCov-19 vaccine (“Vaccine”) in the European Union (the “EU”) is entered into as of 27 August 2020 (the “Effective Date”), by the following parties:
ADVANCE PURCHASE AGREEMENT (“APA”) FOR THE PRODUCTION, PURCHASE AND SUPPLY OF A COVID-19 VACCINE IN THE EUROPEAN UNIONAdvance Purchase Agreement • January 29th, 2021
This Advance Purchase Agreement (this “Agreement”) for the production, purchase and supply of the ChAdOx1 nCov-19 vaccine (“Vaccine”) in the European Union (the “EU”) is entered into as of 27 August 2020 (the “Effective Date”), by the following parties:
ADVANCE PURCHASE AGREEMENT (“APA”) FOR THE PRODUCTION, PURCHASE AND SUPPLY OF A COVID-19 VACCINE IN THE EUROPEAN UNIONAdvance Purchase Agreement • January 29th, 2021
This Advance Purchase Agreement (this “Agreement”) for the production, purchase and supply of the ChAdOx1 nCov-19 vaccine (“Vaccine”) in the European Union (the “EU”) is entered into as of 27 August 2020 (the “Effective Date”), by the following parties:
ADVANCE PURCHASE AGREEMENT (“APA”) FOR THE PRODUCTION, PURCHASE AND SUPPLY OF A COVID-19 VACCINE IN THE EUROPEAN UNIONAdvance Purchase Agreement • January 29th, 2021
This Advance Purchase Agreement (this “Agreement”) for the production, purchase and supply of the ChAdOx1 nCov-19 vaccine (“Vaccine”) in the European Union (the “EU”) is entered into as of 27 August 2020 (the “Effective Date”), by the following parties:
ADVANCE PURCHASE AGREEMENT (“APA”) FOR THE PRODUCTION, PURCHASE AND SUPPLY OF A COVID-19 VACCINE IN THE EUROPEAN UNIONAdvance Purchase Agreement • January 29th, 2021
This Advance Purchase Agreement (this “Agreement”) for the production, purchase and supply of the ChAdOx1 nCov-19 vaccine (“Vaccine”) in the European Union (the “EU”) is entered into as of 27 August 2020 (the “Effective Date”), by the following parties:
